Means and ends of statins and low-density lipoprotein cholesterol lowering

被引：12
|
作者：
LaRosa, John C. [1 ]
机构：
[1] SUNY Downstate Med Ctr, Brooklyn, NY 11203 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2007年 / 50卷 / 05期
关键词：
D O I：
10.1016/j.jacc.2007.04.044
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In the last 2 decades, the benefit of lowering low-density lipoprotein (LDL) cholesterol has been shown beyond reasonable doubt (1,2). Both death and disability from the progress of coronary artery disease can be delayed, and there is recent evidence showing that disabling stroke also can be avoided (3). Few issues in modern medicine have been so thoroughly studied or so consistently shown to be beneficial.
引用
收藏
页码：419 / 420
页数：2
相关论文
共 50 条
  • [31] New Strategies for Lowering Low-Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention
    Sean Paul Gaine
    Renato Quispe
    Jaideep Patel
    Erin D. Michos
    [J]. Current Cardiovascular Risk Reports, 2022, 16 : 69 - 78
  • [32] Intensive lowering of low-density lipoprotein cholesterol prevents the progression of coronary restenosis
    Iwata, A.
    Miura, S.
    Imaizumi, S.
    Shirai, K.
    Mori, K.
    Zhang, B.
    Nishikawa, H.
    Mastuo, K.
    Saku, K.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 578 - 578
  • [33] Effects of Plant Sterols and Stanols Beyond Low-Density Lipoprotein Cholesterol Lowering
    Derdemezis, Christos S.
    Filippatos, Theodosios D.
    Mikhailidis, Dimitri P.
    Elisaf, Moses S.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (02) : 120 - 134
  • [34] Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid
    Ballantyne, Christie M.
    Bays, Harold E.
    Louie, Michael J.
    Smart, Jeremy
    Zhang, Yang
    Ray, Kausik K.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (15):
  • [35] More Progression Toward Regression? Beyond Low-Density Lipoprotein Cholesterol Lowering
    Lewis, Basil S.
    Halon, David A.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (24) : 2743 - 2744
  • [36] The future of low-density lipoprotein cholesterol lowering therapy: An end to statin exceptionalism?
    Khera, Amit V.
    Natarajan, Pradeep
    Kathiresan, Sekar
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (10) : 1062 - 1064
  • [37] Effect of Low-density Lipoprotein Cholesterol Lowering With Alirocumab on Stroke in ODYSSEY OUTCOMES
    Jukema, J. Wouter
    Szarek, Michael
    Zijlstra, Laurien
    Bhatt, Deepak L.
    Bittner, Vera A.
    Diaz, Rafael
    Drexel, Heinz
    Goodman, Shaun G.
    Harrington, Robert A.
    Kim, Yong-Un
    Louie, Michael J.
    Pordy, Robert
    Reiner, Zeljko
    Roe, Matthew T.
    Tse, Hung-Fat
    Valdovinos, Pablo Carlos Montenegro
    White, Harvey D.
    Zeiher, Andreas M.
    Schwartz, Gregory G.
    Steg, Philippe G.
    [J]. CIRCULATION, 2019, 140
  • [38] Raising high-density lipoprotein cholesterol and lowering low-density lipoprotein cholesterol as adjunctive therapy to coronary artery revascularization
    Bates, ER
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (12A): : 28L - 34L
  • [39] New Strategies for Lowering Low-Density Lipoprotein Cholesterol for Cardiovascular Disease Prevention
    Gaine, Sean Paul
    Quispe, Renato
    Patel, Jaideep
    Michos, Erin D.
    [J]. CURRENT CARDIOVASCULAR RISK REPORTS, 2022, 16 (09) : 69 - 78
  • [40] Prolonged and Pronounced Low-Density Lipoprotein Cholesterol Lowering: The Gift That Keeps Giving
    Shapiro, Michael D.
    [J]. CIRCULATION, 2022, 146 (15) : 1120 - 1122
12345